help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Authier, F.
Right arrow Articles by Chauvet, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Authier, F.
Right arrow Articles by Chauvet, G.
Endocrinology Vol. 142, No. 1 276-289
Copyright © 2001 by The Endocrine Society


ARTICLES

Identification of Insulin Domains Important for Binding to and Degradation by Endosomal Acidic Insulinase*

François Authier, Gillian M. Danielsen, Mostafa Kouach, Gilbert Briand and Geneviève Chauvet

Institut National de la Santé et de la Recherche Médicale U510 (F.A.), Faculté de Pharmacie Paris XI, 92296 Châtenay-Malabry, France; Health Care Discovery (G.M.D.), Novo Nordisk A/S, Novo Alle, DK-2880 Bagsvaerd, Denmark; Laboratoire de Spectrométrie de masse (M.K., G.B.), Faculté de Médecine, 59000 Lille, France; Institut National de la Santé et de la Recherche Médicale U30 (G.C.), Hôpital Necker Enfants-Malades, 75015 Paris, France

Address all correspondence and requests for reprints to: François Authier, INSERM U510, Faculté de Pharmacie Paris XI, 5 rue Jean-Baptiste Clément, 92296 Châtenay-Malabry, France. E-mail: francois.authier{at}cep.u-psud.fr

The endosomal compartment of hepatic parenchymal cells contains an acidic endopeptidase, endosomal acidic insulinase (EAI), which hydrolyzes internalized insulin at a limited number of sites. Although the positions of these cleavages are partially known, the residues of insulin important in its binding to and proteolysis by EAI have not been defined. To this end, we have studied the degradation over time of native human insulin and three insulin-analog peptides using a soluble endosomal extract from rat liver parenchyma followed by purification of the products by HPLC and determination of their structure by mass spectrometry. We found variable rates of ligand processing, i.e. high ([AspB10]- and [GluA13,GluB10]-insulin), moderate (insulin) and low (the H2-analog). On the basis of IC50 values, competition studies revealed that human and mutant insulins display nearly equivalent affinity for the EAI. Proteolysis of human and mutant insulins by EAI resulted in eight cleavages in the B-chain which occurred in the central region (GluB13-LeuB17) and at the C-terminus (ArgB22-ThrB27), the latter region comprising the initial cleavages at PheB24-PheB25 (major pathway) and PheB25-TyrB26 (minor pathway) bonds. Except for the [GluA13,GluB10]-insulin mutant, only one cleavage on the A-chain was observed at residues GlnA15-LeuA16. Analysis of the nine cleavage sites showed a preference for hydrophobic and aromatic amino acid residues on both the carboxyl and amino sides of a cleaved peptide bond. Using the B-chain alone as a substrate resulted in a 30-fold increase in affinity for EAI and a 6-fold increase in the rate of hydrolysis compared with native insulin. A similar role for the C-terminal region of the B-chain of insulin in the high-affinity recognition of EAI was supported by the use of the corresponding B22-B30 peptide, which displayed an increase in EAI affinity similar to the entire B-chain vs. wild-type insulin. Thus, we have identified a highly specific molecular interaction of insulin with EAI at the aromatic locus PheB24-PheB25-TyrB26. Analytical subfractionation of a postmitochondrial supernatant fraction showed that a pulse of internalized [125I]TyrA14-H2-analog, a protease-resistant insulin analog, undergoes a greater lysosomal transfer and lesser degradation than [125I]TyrA14-insulin, confirming that endosomal sorting is regulated directly or indirectly by endosomal proteolysis.




This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Authier, P. H. Cameron, C. Merlen, M. Kouach, and G. Briand
Endosomal Proteolysis of Glucagon at Neutral pH Generates the Bioactive Degradation Product Miniglucagon-(19-29)
Endocrinology, December 1, 2003; 144(12): 5353 - 5364.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Desbuquois, G. Chauvet, M. Kouach, and F. Authier
Cell Itinerary and Metabolic Fate of Proinsulin in Rat Liver: In Vivo and in Vitro Studies
Endocrinology, December 1, 2003; 144(12): 5308 - 5321.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Authier, M. Metioui, S. Fabrega, M. Kouach, and G. Briand
Endosomal Proteolysis of Internalized Insulin at the C-terminal Region of the B Chain by Cathepsin D
J. Biol. Chem., March 8, 2002; 277(11): 9437 - 9446.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society